Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hai Liang

Showing results (31-40 of 1,367) with videos related to

Pageof 137
Sort By:
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 14, 2016
[Achievement of Qimin Yaoshu in area of herbalogical textual research]Hai-Liang Zhao, Rui-Xian Zhang
Expert Opinion on Therapeutic Patents|February 3, 2015
Nitroimidazole derivatives: a patent review of US 2014/0141084 A1Peng-Cheng Lv, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|March 19, 2011
Targeted antimicrobial moieties (WO2010080819): patent evaluationZhong-Cheng Song, Hai-Liang Zhu
Optics Letters|November 14, 2006
Symplectic wavelet transformationHong-Yi Fan, Hai-Liang Lu
Acta Crystallographica. Section C, Crystal Structure Communications|December 8, 2004
catena-Poly[[(benzoato-kappaO)silver(I)]-mu-2-aminopyrimidine-kappa2N1:N3]Zhong Lu You, Hai Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|October 7, 2004
Bis(mu-2-aminopyridine)bis[(trifluoroacetato)silver(I)]Zhong Lu You, Hai Liang Zhu
Expert Opinion on Therapeutic Patents|November 20, 2014
EGFR-binding peptide: a patent evaluation of WO2014002836Peng-Cheng Lv, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|August 6, 2005
A novel thiocyanate-bridged dinuclear cadmium(II) complex: di-mu-thiocyanato-bis((methanol){4-nitro-2-[2-(dimethylamino)ethyliminomethyl]phenolato}cadmium(II))Zhong Lu You, Hai Liang Zhu
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2003
Small nucleolar RNA interference induced by antisense or double-stranded RNA in trypanosomatidsXue-Hai Liang, Qing Liu, Shulamit Michaeli
Current Topics in Medicinal Chemistry|April 4, 2020
Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor TherapyChongchen Zhou, Hai-Liang Zhu, Yongtao Duan
Pageof 137

Showing results (31-40 of 1,367) with videos related to

Sort By:
Pageof 137
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 14, 2016
[Achievement of Qimin Yaoshu in area of herbalogical textual research]Hai-Liang Zhao, Rui-Xian Zhang
Expert Opinion on Therapeutic Patents|February 3, 2015
Nitroimidazole derivatives: a patent review of US 2014/0141084 A1Peng-Cheng Lv, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|March 19, 2011
Targeted antimicrobial moieties (WO2010080819): patent evaluationZhong-Cheng Song, Hai-Liang Zhu
Optics Letters|November 14, 2006
Symplectic wavelet transformationHong-Yi Fan, Hai-Liang Lu
Acta Crystallographica. Section C, Crystal Structure Communications|December 8, 2004
catena-Poly[[(benzoato-kappaO)silver(I)]-mu-2-aminopyrimidine-kappa2N1:N3]Zhong Lu You, Hai Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|October 7, 2004
Bis(mu-2-aminopyridine)bis[(trifluoroacetato)silver(I)]Zhong Lu You, Hai Liang Zhu
Expert Opinion on Therapeutic Patents|November 20, 2014
EGFR-binding peptide: a patent evaluation of WO2014002836Peng-Cheng Lv, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|August 6, 2005
A novel thiocyanate-bridged dinuclear cadmium(II) complex: di-mu-thiocyanato-bis((methanol){4-nitro-2-[2-(dimethylamino)ethyliminomethyl]phenolato}cadmium(II))Zhong Lu You, Hai Liang Zhu
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2003
Small nucleolar RNA interference induced by antisense or double-stranded RNA in trypanosomatidsXue-Hai Liang, Qing Liu, Shulamit Michaeli
Current Topics in Medicinal Chemistry|April 4, 2020
Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor TherapyChongchen Zhou, Hai-Liang Zhu, Yongtao Duan
Pageof 137